Kate Haviland
Director · 3 filings · Latest: Jun 30, 2026
Avalyn Pharma Inc.
Bicara Therapeutics Inc.
Fulcrum Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
— | KATHRYN D HAVILAND | — | Apr 1, 2025 | Proposed Sale | $88.51 | 2,498 | $221.1K | — | |
— | KATHRYN D HAVILAND | — | Nov 29, 2024 | Proposed Sale | $95.10 | 3,799 | $361.3K | — | |